The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A longitudinal study of brain atrophy in relapsing multiple sclerosis
Abstract
OBJECTIVE: To determine if progressive brain atrophy could be detected over 1- and 2-year intervals in relapsing MS, based on annual MR studies from the Multiple Sclerosis Collaborative Research Group (MSCRG) trial of interferon beta-1a (Avonex). METHODS: All subjects had mild to moderate disability, with baseline expanded disability status scores ranging from 1.0 to 3.5, and at least two relapses in the 3 years before study entry. Atrophy measures included third and lateral ventricle width, brain width, and corpus callosum area. RESULTS: Significant increases were detected in third ventricle width at year 2 and lateral ventricle width at 1 and 2 years. Significant decreases in corpus callosum area and brain width were also observed at 1 and 2 years. Multiple regression analyses suggested that the number of gadolinium-enhancing lesions at baseline was the single significant contributor to change in third ventricle width. Atrophy over 1 and 2 years as indicated by enlargement of the third and lateral ventricle and shrinkage of the corpus callosum was greater for patients entering the trial with enhancing lesions. Greater disability increments over 1 and 2 years were associated with more severe third ventricle enlargement. CONCLUSION: In patients with relapsing MS and only mild to moderate disability, significant cerebral atrophy is already developing that can be measured over periods of only 1 to 2 years. The course of cerebral atrophy in MS appears to be influenced by prior inflammatory disease activity as indicated by the presence of enhancing lesions. Brain atrophy measures are important markers of MS disease progression because they likely reflect destructive and irreversible pathologic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationIntramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
Self-citationThe IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995) · Neurology · doi:10.1212/wnl.45.7.1277 · Cited by 916
Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 643
Self-citationCorrelation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis
Rao, S. M., Leo, G. J., Haughton, V. M., Aubin-Faubert, P. S., & Bernardin, L. (1989) · Neurology · doi:10.1212/wnl.39.2.161 · Cited by 516
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Self-citationTruyen, L., van Waesberghe, J. H. T. M., van Walderveen, M. A. A., van Oosten, B. W., Polman, C. H., Hommes, O. R., Ader, H. J. A., & Barkhof, F. (1996) · Neurology · doi:10.1212/wnl.47.6.1469 · Cited by 462
Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444
Self-citationKatz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340507 · Cited by 387
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., & Miller, D. H. (1995) · Brain · doi:10.1093/brain/118.6.1583 · Cited by 377
Self-citationCorrelation of magnetization transfer ration with clinical disability in multiple sclerosis
Gass, A., Barker, G. J., Kidd, D., Thorpe, J. W., MacManus, D., Brennan, A., Tofts, P. S., Thompson, A. J., McDonald, W. I., & Miller, D. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360113 · Cited by 343
Self-citationSpinal cord MRI using multi‐array coils and fast spin echo: II. Findings in multiple sclerosis
Kidd, D., Thorpe, J. W., Thompson, A. J., Kendall, B. E., Moseley, I. F., MacManus, D. G., McDonald, W. I., & Miller, D. H. (1993) · Neurology · doi:10.1212/wnl.43.12.2632 · Cited by 340
Self-citationMagnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis
Simon, J. H., Jacobs, L. D., Campion, M., Wende, K., Simonian, N., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430114 · Cited by 330
Self-citationChemical pathology of acute demyelinating lesions and its correlation with disability
De Stefano, N., Matthews, P. M., Antel, J. P., Preul, M., Francis, G., & Arnold, D. L. (1995) · Annals of Neurology · doi:10.1002/ana.410380610 · Cited by 304
Filippi, M., Paty, D. W., Kappos, L., Barkhof, F., Compston, D. A. S., Thompson, A. J., Zhao, G. J., Wiles, C. M., McDonald, W. I., & Miller, D. H. (1995) · Neurology · doi:10.1212/wnl.45.2.255 · Cited by 296
Self-citationThe longstanding MS lesion. A quantitative MRI and electron microscopic study
BARNES, D., MUNRO, P. M. G., YOUL, B. D., PRINEAS, J. W., & MCDONALD, W. I. (1991) · Brain · doi:10.1093/brain/114.3.1271 · Cited by 256
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
Rudick, R. A., Goodkin, D. E., Jacobs, L. D., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Granger, C. V., Simon, J. H., et al. (1997) · Neurology · doi:10.1212/wnl.49.2.358 · Cited by 232
Self-citationMRI dynamics of brain and spinal cord in progressive multiple sclerosis.
Kidd, D., Thorpe, J. W., Kendall, B. E., Barker, G. J., Miller, D. H., McDonald, W. I., & Thompson, A. J. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.15 · Cited by 196
Self-citationNEWCOMBE, J., HAWKINS, C. P., HENDERSON, C. L., PATEL, H. A., WOODROOFE, M. N., HAYES, G. M., CUZNER, M. L., MACMANUS, D., BOULAY, E. P. G. H. D., & MCDONALD, W. I. (1991) · Brain · doi:10.1093/brain/114.2.1013 · Cited by 171
Molyneux, P. D., Filippi, M., Barkhof, F., Gasperini, C., Yousry, T. A., Lruyen, L., Lai, H. M., Rocca, M. A., MOSELEY, I. F., & Miller, D. H. (1998) · Annals of Neurology · doi:10.1002/ana.410430311 · Cited by 168
Self-citationMagnetic Resonance Imaging Correlates of Dementia in Multiple Sclerosis
Huber, S. J., Paulson, G. W., Shuttleworth, E. C., Chakeres, D., Clapp, L. E., Pakalnis, A., Weiss, K., & Rammohan, K. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520190040015 · Cited by 164
Hippocampal vulnerability to stress and aging: possible role of neurotrophic factors
Smith, M. A. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00220-0 · Cited by 158
Jacobs, L., Cookfair, D. L., Rudick, R., Herndon, R. M., Richert, J. R., Salazar, A., Fischer, J., Goodkin, D., Granger, C. V., Simon, J., et al. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100210 · Cited by 122
Self-citationA spinal cord MRI study of benign and secondary progressive multiple sclerosis
Filippi, M., Campi, A., Colombo, B., Pereira, C., Martinelli, V., Baratti, C., & Comı, G. (1996) · Journal of Neurology · doi:10.1007/bf00886870 · Cited by 110
Ogawa, T., Yoshida, Y., Okudera, T., Noguchi, K., Kado, H., & Uemura, K. (1997) · Radiology · doi:10.1148/radiology.204.1.9205256 · Cited by 109
Pozzilli, C., Bastianello, S., Koudriavtseva, T., Gasperini, C., Bozzao, A., Millefiorini, E., Galgani, S., Buttinelli, C., Perciaccante, G., Piazza, G., et al. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.251 · Cited by 106
Loevner, L. A., Grossman, R. I., McGowan, J. C., Ramer, K., & Cohen, J. A. (1995) · PubMed Central · Cited by 105
Koudriavtseva, T., Thompson, A. J., Fiorelli, M., Gasperini, C., Bastianello, S., Bozzao, A., Paolillo, A., Pisani, A., Galgani, S., & Pozzilli, C. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.285 · Cited by 95
Functional and Magnetic Resonance Imaging Correlates of Callosal Involvement in Multiple Sclerosis
Pelletier, J., Habib, M., Lyon‐Caen, O., Salamon, G., Poncet, M., & Khalil, R. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540100066018 · Cited by 92
From enhancing lesions to brain atrophy in relapsing MS
Simon, J. H. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00075-2 · Cited by 74
Self-citationQuantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
Simon, J. H., Schiffer, R. B., Rudick, R. A., & Herndon, R. M. (1987) · PubMed · Cited by 73
Self-citationFilippi, M., Mastronardo, G., Rocca, M. A., Pereira, C., & Comi, G. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00110-5 · Cited by 68
Multiple Sclerosis and Corpus Callosum Atrophy: Relationship of MRI Findings to Clinical Data
Dietemann, J., Beigelmann, C., Vouge, M., et al. (1989) · Springer eBooks · doi:10.1007/978-3-642-74337-5_116 · Cited by 60
Multiple sclerosis and corpus callosum atrophy: Relationship of MRI findings to clinical data
Dietemann, J., Beigelman‐Aubry, C., Rumbach, L., Vouge, M., Tajahmady, T., Faubert, C., Jeung, M., & Wackenheim, A. (1988) · Neuroradiology · doi:10.1007/bf00339686 · Cited by 52
Giugni, E., Pozzilli, C., Bastianello, S., Gasperini, C., Paolillo, A., Koudriavtseva, T., Frontoni, M., Farina, D., & Bozzao, L. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300401 · Cited by 37
Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
Simon, J. H. (1996) · Europe PMC (PubMed Central) · Cited by 10
Self-citation
Cited by
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
Rudick, R. A., Fisher, E., Lee, J.-C., Simon, J., Jacobs, L., & the Multiple Sclerosis Collaborative Research Group (1999) · Neurology · doi:10.1212/wnl.53.8.1698 · Cited by 736
Self-citationMiller, D. H. (2002) · Brain · doi:10.1093/brain/awf177 · Cited by 631
Self-citationVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
Metadata
- Authors
- Simon, J. H., Jacobs, L. D., Campion, M. K., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Simonian, N., Lajaunie, M., Miller, D. E., Wende, K., Martens-Davidson, A., Kinkel, R. P., Munschauer, F. E., Brownscheidle, C. M., & The Multiple Sclerosis Collaborative Research Group (MSCRG)
- Venue
- Neurology
- Published
- 1999-07
- Volume
- 53
- Issue
- 1
- Pages
- 139-139
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2116064638
- Cited by
- 340
- References
- 36
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.